A dose-dependent cell-cycle arrest in MM-cells treated with Erk1/2i + CDK4/6i is evidenced by increased expression of the CDK inhibitor protein p27 (Fig. 3A2–3). Here, MAPK3 is linked to Miyoshi myopathy.